Multiplexed Analyte Detection System Development

The contract seeks the development and validation of advanced diagnostic systems capable of multiplexed detection of multiple pathogens or biomarkers in a single test run, with stringent requirements for high sensitivity and minimal cross-reactivity between targets. This effort is focused on creating a robust, reliable platform that can simultaneously identify diverse analytes without compromising accuracy or performance, making it suitable for complex clinical or public health scenarios. The technology must demonstrate feasibility through rigorous validation protocols to ensure consistent results across varied sample types and environmental conditions. The action is structured as a subcontract under the Department of Health and Human Services, specifically managed by the ASPR Barda Division Contracts Management & Acq, and is aligned with NAICS code 541715 for research and development in the physical, engineering, and life sciences. Proposals must be submitted by July 17, 2026, with performance expected to be centered in Washington. The solicitation does not specify set-aside provisions or point of contact, but interested parties are directed to the official SAM.gov portal for detailed submission guidelines and further administrative requirements.